Stay updated on Pembrolizumab in Kaposi's Sarcoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Kaposi's Sarcoma Clinical Trial page.

Latest updates to the Pembrolizumab in Kaposi's Sarcoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedAdded a clarifying note that PubMed-listed publications are automatically filled in and may not all pertain to the study, and updated the revision to v3.3.2, while removing the previous language stating that publications come from PubMed and are automatically generated by ClinicalTrials.gov with the NCT number (v3.2.0).SummaryDifference0.1%

- Check28 days agoChange DetectedThe government funding/operating status notice on the page was removed; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check42 days agoChange DetectedThe study details page appears unchanged between screenshots; all sections including eligibility criteria, outcomes, and contact information look consistent.SummaryDifference0.5%

- Check71 days agoChange DetectedSummary of changes: added a government funding notice with current operating status guidance and updated version to v3.2.0; removed the old version label v3.1.0.SummaryDifference3%

- Check78 days agoChange DetectedMinor content refresh: correcting the disease name formatting, updating to revision v3.1.0, and adding contact/identifier details.SummaryDifference0.1%

- Check93 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the Back to Top link was removed.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab in Kaposi's Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Kaposi's Sarcoma Clinical Trial page.